Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunogenicity and safety of different doses of split, inactivated, trivalent influenza vaccine (Fluzone) administered by intradermal and intramuscular route in healthy adults (a randomized, prospective, active-controlled, single-center, open-label, dose-ranging study)

Trial Profile

Immunogenicity and safety of different doses of split, inactivated, trivalent influenza vaccine (Fluzone) administered by intradermal and intramuscular route in healthy adults (a randomized, prospective, active-controlled, single-center, open-label, dose-ranging study)

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2013

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top